Most people expect to be compensated for their time when they provide a service, except when that service is clearly intended to be voluntary. When it comes to engaging patients, there is a persistent question of whether those patients should be compensated for their time. This post explores the issue of whether we can achieve equitable compensation for patients who contribute to observational or clinical research, not as human subjects, but as part of the research team.
Read MoreModern patient engagement regulatory policy has its origins in the HIV/AIDS advocacy movement. Legislation in 2012 provided FDA with the power to initiate several new patient-focused initiatives. There has never been a better time for the patient voice to be heard by regulatory decision-makers.
Read More